Merck CEO Responds to RFK Jr.'s Dismissal of CDC Vaccine Advisory Committee

Merck CEO's Reaction to CDC Committee Changes

• 🎯 Merck CEO Rob Davis commented on RFK Jr.'s decision to remove all 17 members of the CDC's vaccine advisory committee.
• ⚠️ Davis acknowledged that the full implications of this move are still unclear and depend on who replaces the dismissed members.

Impact on Merck's RSV Vaccine

• 💉 Merck recently received FDA approval for an RSV vaccine for babies and is awaiting the June ACIP meeting for a recommendation.
• 🗓️ The company is proceeding with plans for the vaccine's launch this fall, with the meeting still expected to occur in two weeks.
• 📈 Despite confidence in vaccine safety and efficacy, the situation presents a risk for the company.

Confidence in Vaccine Safety

• ✅ Davis expressed strong confidence in the safety and efficacy of Merck's vaccines, regardless of the committee changes.
• ❓ He emphasized the need to observe the new committee members and how the process unfolds before drawing further conclusions.